Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Vilchèze

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Microbiology Spectrum|March 25, 2017
Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch ParadoxCatherine Vilchèze, Laurent Kremer
Microbiology Spectrum|June 25, 2015
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and CausalitiesCatherine Vilchèze, William R Jacobs
Journal of Molecular Biology|February 25, 2019
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosisCatherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy|July 25, 2012
The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosisCatherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy|February 23, 2021
The promises and limitations of <i>N-</i>acetylcysteine as a potentiator of first-line and second-line tuberculosis drugsCatherine Vilchèze, William R Jacobs
Current Protocols in Microbiology|September 5, 2008
Isolation and analysis of Mycobacterium tuberculosis mycolic acidsCatherine Vilchèze, William R Jacobs
Annual Review of Microbiology|November 24, 2007
The mechanism of isoniazid killing: clarity through the scope of geneticsCatherine Vilchèze, William R Jacobs
Biorxiv : the Preprint Server for Biology|September 16, 2024
Intravenous Immunization with Triple Auxotrophs of <i>Mycobacterium tuberculosis</i> : A novel vaccine strategy against tuberculosisCatherine Vilchèze, Saranathan Rajagopalan, William R Jacobs
Journal of Bacteriology|June 19, 2004
Characterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) geneOren Zimhony, Catherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy|January 5, 2018
Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in MiceCatherine Vilchèze, John Kim, William R Jacobs
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Microbiology Spectrum|March 25, 2017
Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch ParadoxCatherine Vilchèze, Laurent Kremer
Microbiology Spectrum|June 25, 2015
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and CausalitiesCatherine Vilchèze, William R Jacobs
Journal of Molecular Biology|February 25, 2019
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosisCatherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy|July 25, 2012
The combination of sulfamethoxazole, trimethoprim, and isoniazid or rifampin is bactericidal and prevents the emergence of drug resistance in Mycobacterium tuberculosisCatherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy|February 23, 2021
The promises and limitations of <i>N-</i>acetylcysteine as a potentiator of first-line and second-line tuberculosis drugsCatherine Vilchèze, William R Jacobs
Current Protocols in Microbiology|September 5, 2008
Isolation and analysis of Mycobacterium tuberculosis mycolic acidsCatherine Vilchèze, William R Jacobs
Annual Review of Microbiology|November 24, 2007
The mechanism of isoniazid killing: clarity through the scope of geneticsCatherine Vilchèze, William R Jacobs
Biorxiv : the Preprint Server for Biology|September 16, 2024
Intravenous Immunization with Triple Auxotrophs of <i>Mycobacterium tuberculosis</i> : A novel vaccine strategy against tuberculosisCatherine Vilchèze, Saranathan Rajagopalan, William R Jacobs
Journal of Bacteriology|June 19, 2004
Characterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) geneOren Zimhony, Catherine Vilchèze, William R Jacobs
Antimicrobial Agents and Chemotherapy|January 5, 2018
Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in MiceCatherine Vilchèze, John Kim, William R Jacobs
Pageof 7